TETRACAINE

TETRACAINE was reported 395 times

TETRACAINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INJURY OF CONJUNCTIVA 1 0.1429
1 DIAPEDESIS 2 0.1176
2 PERIORBITAL FAT HERNIATION 2 0.1176
3 AQUEOUS FIBRIN 3 0.0588
4 TRANSURETHRAL RESECTION SYNDROME 1 0.0400
5 CORNEAL EPITHELIUM DEFECT 22 0.0379
6 RETINAL PIGMENT EPITHELIUM CHANGE 1 0.0345
7 EXPOSURE VIA MUCOSA 2 0.0333
8 CHORIORETINAL FOLDS 2 0.0282
9 THYROID STIMULATING IMMUNOGLOBULIN INCREASED 2 0.0250
10 KERATOPLASTY 1 0.0238
11 CIRCUMORAL SWELLING 3 0.0234
12 BACTERIAL ENDOPHTHALMITIS 6 0.0226
13 CORNEAL INFILTRATES 7 0.0223
14 NASAL VALVE COLLAPSE 1 0.0204
15 TOXIC ANTERIOR SEGMENT SYNDROME 20 0.0183
16 RETINAL DRUSEN 3 0.0183
17 CORNEAL TOXICITY 2 0.0180
18 HYPOPYON 13 0.0157
19 CONJUNCTIVAL ULCER 2 0.0145
20 HARLEQUIN SYNDROME 1 0.0137
21 DERMATOCHALASIS 2 0.0136
22 PERIPHLEBITIS 1 0.0135
23 AUTOPHONY 1 0.0133
24 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 16 0.0129
25 POSTERIOR CAPSULE RUPTURE 1 0.0127
26 PAPILLARY CYSTADENOMA LYMPHOMATOSUM 1 0.0127
27 RETINAL CYST 2 0.0120
28 MACULAR PIGMENTATION 1 0.0119
29 OPHTHALMOLOGICAL EXAMINATION ABNORMAL 2 0.0113
30 DEAFNESS PERMANENT 2 0.0102
31 PSEUDOENDOPHTHALMITIS 1 0.0101
32 PHARYNGEAL STENOSIS 1 0.0097
33 PINGUECULA 1 0.0094
34 CATARACT NUCLEAR 6 0.0090
35 UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE 1 0.0084
36 IRIS NEOVASCULARISATION 1 0.0080
37 ANTI-THYROID ANTIBODY INCREASED 1 0.0079
38 ANTERIOR CHAMBER FIBRIN 1 0.0078
39 NEOVASCULARISATION 2 0.0076
40 RETINOSCHISIS 1 0.0072
41 MYOCARDIAL STRAIN 1 0.0072
42 PH BODY FLUID ABNORMAL 1 0.0072
43 SUPRAVENTRICULAR TACHYARRHYTHMIA 1 0.0071
44 RETINOPATHY HYPERTENSIVE 2 0.0066
45 VITREOUS HAZE 1 0.0065
46 CORNEAL LESION 2 0.0065
47 CORNEAL DECOMPENSATION 1 0.0062
48 VITREOUS DEGENERATION 1 0.0061
49 CORNEAL SCAR 3 0.0060
50 DIABETIC RETINAL OEDEMA 3 0.0059
51 POSTERIOR CAPSULE OPACIFICATION 2 0.0058
52 SUBRETINAL FLUID 6 0.0055
53 ENDOPHTHALMITIS 32 0.0053
54 SUBRETINAL FIBROSIS 1 0.0051
55 CORNEAL OPACITY 7 0.0051
56 EYELID SENSORY DISORDER 1 0.0051
57 CARDIAC NEOPLASM UNSPECIFIED 1 0.0050
58 RETINAL TOXICITY 5 0.0049
59 VENTRICULAR DYSKINESIA 1 0.0048
60 LENS DISLOCATION 1 0.0048
61 ENDOCRINE OPHTHALMOPATHY 4 0.0046
62 SINUS ARRHYTHMIA 6 0.0046
63 HYPERINSULINAEMIC HYPOGLYCAEMIA 1 0.0045
64 VERY LOW DENSITY LIPOPROTEIN INCREASED 1 0.0045
65 MACULAR FIBROSIS 3 0.0044
66 PUNCTATE KERATITIS 4 0.0044
67 ANTERIOR CHAMBER DISORDER 1 0.0043
68 HYPOGONADISM MALE 1 0.0043
69 ANTERIOR CHAMBER CELL 3 0.0042
70 VITREOUS DETACHMENT 9 0.0041
71 CORNEAL NEOVASCULARISATION 1 0.0040
72 INTRAOCULAR LENS IMPLANT 2 0.0040
73 CORNEAL OEDEMA 9 0.0040
74 RETINAL NEOVASCULARISATION 1 0.0040
75 GLARE 2 0.0039
76 APNOEA NEONATAL 1 0.0039
77 HYPHAEMA 2 0.0038
78 CUTIS LAXA 1 0.0037
79 EYE OEDEMA 9 0.0037
80 PRODUCT INFORMATION CONTENT COMPLAINT 1 0.0036
81 CHOROIDAL NEOVASCULARISATION 3 0.0035
82 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 3 0.0034
83 ANTERIOR CHAMBER INFLAMMATION 2 0.0034
84 RETINAL DEPIGMENTATION 1 0.0033
85 NEPHRITIC SYNDROME 1 0.0032
86 RETINAL EXUDATES 3 0.0032
87 EXTRAOCULAR MUSCLE DISORDER 1 0.0031
88 APPLICATION SITE OEDEMA 1 0.0031
89 PULMONARY ARTERY DILATATION 1 0.0029
90 TACHYPHYLAXIS 1 0.0029
91 MUSCLE HYPERTROPHY 1 0.0028
92 COLOUR BLINDNESS ACQUIRED 1 0.0028
93 ELECTROCARDIOGRAM T WAVE INVERSION 6 0.0027
94 NASAL TURBINATE HYPERTROPHY 1 0.0027
95 CORNEAL DYSTROPHY 1 0.0024
96 MANTLE CELL LYMPHOMA RECURRENT 1 0.0023
97 CORNEAL ABRASION 3 0.0022
98 RETINAL SCAR 1 0.0022
99 METAMORPHOPSIA 4 0.0022
100 VITRITIS 4 0.0022
101 RETINAL OEDEMA 4 0.0021
102 FOREIGN BODY IN EYE 2 0.0021
103 TYPE V HYPERLIPIDAEMIA 1 0.0021
104 PO2 INCREASED 1 0.0020
105 IRIS ADHESIONS 1 0.0019
106 CORNEAL EROSION 1 0.0019
107 BODY FAT DISORDER 1 0.0018
108 PRESBYOPIA 1 0.0018
109 BACTERIAL TEST POSITIVE 4 0.0018
110 ECZEMA EYELIDS 1 0.0018
111 BONE FRAGMENTATION 1 0.0018
112 NAIL BED BLEEDING 1 0.0018
113 EMBOLISM ARTERIAL 2 0.0017
114 PUPILLARY DISORDER 1 0.0016
115 CATARACT SUBCAPSULAR 1 0.0016
116 PUPILLARY REFLEX IMPAIRED 3 0.0016
117 DERMATOSIS 1 0.0016
118 CYSTOID MACULAR OEDEMA 3 0.0016
119 VASODILATATION 4 0.0016
120 CHALAZION 1 0.0016
121 CHORIORETINITIS 1 0.0016
122 RETINAL DEGENERATION 2 0.0015
123 COMPUTERISED TOMOGRAM THORAX ABNORMAL 1 0.0015
124 EYE INFLAMMATION 13 0.0014
125 ASTIGMATISM 2 0.0013
126 RETINAL INJURY 1 0.0013
127 ROSACEA 6 0.0013
128 IRIDOCYCLITIS 4 0.0013
129 WOUND DRAINAGE 1 0.0013
130 SINUSITIS FUNGAL 1 0.0012
131 OCULAR VASCULAR DISORDER 1 0.0012
132 NEONATAL HYPOXIA 1 0.0012
133 SEROUS RETINAL DETACHMENT 1 0.0012
134 VITREOUS OPACITIES 1 0.0012
135 NON-INFECTIOUS ENDOPHTHALMITIS 1 0.0012
136 MALIGNANT HYPERTENSION 1 0.0012
137 OPTICAL COHERENCE TOMOGRAPHY ABNORMAL 1 0.0012
138 RETINAL DISORDER 3 0.0012
139 VITREOUS FLOATERS 11 0.0011
140 BLOOD SODIUM INCREASED 3 0.0011
141 CERUMEN IMPACTION 1 0.0011
142 VITREOUS HAEMORRHAGE 3 0.0011
143 VENOUS INJURY 1 0.0011
144 STRESS CARDIOMYOPATHY 6 0.0010
145 BRAIN HYPOXIA 1 0.0010
146 INJECTION SITE NECROSIS 2 0.0010
147 CONJUNCTIVAL OEDEMA 1 0.0010
148 PHOTOPSIA 6 0.0009
149 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0009
150 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 1 0.0009
151 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 2 0.0009
152 DRY AGE-RELATED MACULAR DEGENERATION 1 0.0009
153 ARTERIAL HAEMORRHAGE 1 0.0009
154 WOUND COMPLICATION 3 0.0009
155 ALLODYNIA 1 0.0009
156 DEVICE DISPENSING ERROR 1 0.0008
157 PRODUCT CONTAMINATION MICROBIAL 1 0.0008
158 RETINAL TEAR 2 0.0008
159 NOCTURNAL DYSPNOEA 1 0.0008
160 STENOTROPHOMONAS INFECTION 1 0.0007
161 ULCERATIVE KERATITIS 2 0.0007
162 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 1 0.0007
163 PERIODONTAL DISEASE 1 0.0007
164 MAST CELL ACTIVATION SYNDROME 1 0.0007
165 AUDITORY DISORDER 1 0.0007
166 DERMATITIS CONTACT 8 0.0007
167 COMPLEX REGIONAL PAIN SYNDROME 1 0.0007
168 EYE INJURY 2 0.0007
169 KERATITIS 2 0.0007
170 MEAN CELL VOLUME DECREASED 1 0.0006
171 RESPIRATORY RATE DECREASED 2 0.0006
172 FUNGAEMIA 1 0.0006
173 DEAFNESS NEUROSENSORY 2 0.0006
174 BLOOD PH DECREASED 1 0.0006
175 ANAPHYLACTIC SHOCK 15 0.0006
176 RETINITIS 1 0.0006
177 MUSCLE CONTRACTIONS INVOLUNTARY 2 0.0006
178 TYPE I HYPERSENSITIVITY 2 0.0006
179 FACIAL PARESIS 2 0.0006
180 TETANY 1 0.0005
181 EYE DISORDER 18 0.0005
182 BLINDNESS TRANSIENT 4 0.0005
183 VISUAL ACUITY REDUCED 18 0.0005
184 OPPORTUNISTIC INFECTION 1 0.0005
185 MACULAR OEDEMA 3 0.0005
186 LIP DISORDER 1 0.0005
187 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
188 THYROID MASS 2 0.0005
189 OCULAR HYPERTENSION 1 0.0005
190 ATROPHY 1 0.0005
191 NASAL SEPTUM DEVIATION 1 0.0005
192 SUSPECTED COUNTERFEIT PRODUCT 2 0.0005
193 AZOTAEMIA 2 0.0005
194 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 3 0.0005
195 PHOTOPHOBIA 9 0.0005
196 OPTIC NEUROPATHY 1 0.0005
197 FOREIGN BODY SENSATION IN EYES 3 0.0005
198 INFLAMMATION 24 0.0005
199 GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0005
200 CLOSTRIDIUM TEST POSITIVE 1 0.0005
201 RETINAL DETACHMENT 4 0.0004
202 EYE OPERATION 2 0.0004
203 APHTHOUS STOMATITIS 1 0.0004
204 METHAEMOGLOBINAEMIA 1 0.0004
205 HYPERTRANSAMINASAEMIA 3 0.0004
206 SINUS PAIN 1 0.0004
207 BLINDNESS UNILATERAL 6 0.0004
208 RETINAL HAEMORRHAGE 3 0.0004
209 SLOW SPEECH 1 0.0004
210 JUVENILE IDIOPATHIC ARTHRITIS 1 0.0004
211 DERMATITIS EXFOLIATIVE 2 0.0004
212 INTRAOCULAR PRESSURE INCREASED 5 0.0004
213 EYE DISCHARGE 4 0.0004
214 LARYNGOSPASM 1 0.0004
215 EAR CONGESTION 1 0.0004
216 SKIN WRINKLING 1 0.0004
217 SUBDURAL HAEMORRHAGE 1 0.0004
218 LUNG CONSOLIDATION 1 0.0004
219 ENDOTRACHEAL INTUBATION 1 0.0004
220 NEUTROPHIL COUNT ABNORMAL 1 0.0004
221 EYELID MARGIN CRUSTING 1 0.0003
222 STRABISMUS 1 0.0003
223 EYE PAIN 19 0.0003
224 SQUAMOUS CELL CARCINOMA OF SKIN 2 0.0003
225 BONE MARROW DISORDER 1 0.0003
226 IRITIS 1 0.0003
227 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
228 DRUG EFFECT INCREASED 1 0.0003
229 OCULAR HYPERAEMIA 15 0.0003
230 BLADDER PAIN 1 0.0003
231 POSTURE ABNORMAL 1 0.0003
232 HIGH DENSITY LIPOPROTEIN DECREASED 1 0.0003
233 EYE HAEMORRHAGE 4 0.0003
234 DIABETIC RETINOPATHY 1 0.0003
235 DEFAECATION URGENCY 2 0.0003
236 NEUROTOXICITY 5 0.0003
237 CONJUNCTIVAL HYPERAEMIA 1 0.0003
238 EYE IRRITATION 16 0.0003
239 RENAL TRANSPLANT 1 0.0003
240 VISUAL FIELD DEFECT 2 0.0003
241 BLINDNESS 11 0.0003
242 CARDIAC DYSFUNCTION 1 0.0003
243 RETINOPATHY 1 0.0003
244 OCULAR DISCOMFORT 3 0.0003
245 CHRONIC SINUSITIS 1 0.0003
246 SNORING 1 0.0003
247 AUTOIMMUNE THYROIDITIS 1 0.0003
248 PARANASAL SINUS DISCOMFORT 1 0.0003
249 POST PROCEDURAL COMPLICATION 5 0.0003
250 APNOEA 2 0.0003
251 THROAT CANCER 1 0.0002
252 VITAMIN D DECREASED 2 0.0002
253 ABNORMAL SENSATION IN EYE 1 0.0002
254 DIPLOPIA 6 0.0002
255 MONOPLEGIA 1 0.0002
256 DIVERTICULUM INTESTINAL 1 0.0002
257 DYSPHEMIA 1 0.0002
258 LIGAMENT RUPTURE 1 0.0002
259 CYTOMEGALOVIRUS VIRAEMIA 1 0.0002
260 DRUG TOXICITY 3 0.0002
261 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
262 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
263 PATHOGEN RESISTANCE 2 0.0002
264 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
265 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
266 NEPHROGENIC ANAEMIA 1 0.0002
267 CONJUNCTIVITIS 4 0.0002
268 SKIN TIGHTNESS 1 0.0002
269 ATELECTASIS 2 0.0002
270 BRAIN INJURY 2 0.0002
271 ERYSIPELAS 1 0.0002
272 CORONARY ARTERY STENOSIS 1 0.0002
273 CORONARY ARTERIAL STENT INSERTION 1 0.0002
274 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
275 VENTRICULAR EXTRASYSTOLES 2 0.0002
276 TONSILLITIS 1 0.0002
277 DERMATITIS 4 0.0002
278 NYSTAGMUS 1 0.0002
279 OVERWEIGHT 1 0.0002
280 ERYTHEMA OF EYELID 1 0.0002
281 NORMAL NEWBORN 1 0.0002
282 VISION BLURRED 25 0.0002
283 MENTAL STATUS CHANGES 5 0.0002
284 ANGIOPATHY 1 0.0002
285 PERIORBITAL SWELLING 1 0.0002
286 CORONARY ARTERY BYPASS 1 0.0002
287 MOUTH SWELLING 1 0.0002
288 HYPERVENTILATION 1 0.0002
289 DYSKINESIA 7 0.0002
290 EYELID OEDEMA 2 0.0002
291 HYPOXIA 6 0.0002
292 URINE ODOUR ABNORMAL 1 0.0002
293 CATARACT 10 0.0002
294 TYPE 1 DIABETES MELLITUS 1 0.0002
295 LACRIMATION INCREASED 5 0.0002
296 VISUAL IMPAIRMENT 20 0.0002
297 SECRETION DISCHARGE 2 0.0002
298 SWELLING OF EYELID 1 0.0002
299 HERPES SIMPLEX 1 0.0002
300 METASTASES TO LYMPH NODES 1 0.0001
301 THROAT TIGHTNESS 4 0.0001
302 ULCER HAEMORRHAGE 1 0.0001
303 UVEITIS 2 0.0001
304 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
305 LARGE INTESTINE POLYP 1 0.0001
306 APPLICATION SITE REACTION 1 0.0001
307 PAPULE 1 0.0001
308 DUODENAL ULCER 1 0.0001
309 SINUS TACHYCARDIA 2 0.0001
310 IMPAIRED QUALITY OF LIFE 2 0.0001
311 GRAFT VERSUS HOST DISEASE 1 0.0001
312 SENSITIVE SKIN 1 0.0001
313 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
314 EYE SWELLING 5 0.0001
315 HYDRONEPHROSIS 1 0.0001
316 TROPONIN INCREASED 1 0.0001
317 AORTIC ANEURYSM 1 0.0001
318 PHARYNGEAL OEDEMA 2 0.0001
319 ATRIOVENTRICULAR BLOCK 1 0.0001
320 HAEMORRHAGIC STROKE 1 0.0001
321 CYANOSIS 2 0.0001
322 PRODUCT USE COMPLAINT 2 0.0001
323 BLOOD ALBUMIN DECREASED 1 0.0001
324 POST PROCEDURAL INFECTION 1 0.0001
325 HYPERAESTHESIA 1 0.0001
326 EOSINOPHIL COUNT INCREASED 1 0.0001
327 EYE PRURITUS 4 0.0001
328 PSEUDOMONAS INFECTION 1 0.0001
329 RASH GENERALISED 3 0.0001
330 PULMONARY OEDEMA 5 0.0001
331 END STAGE RENAL DISEASE 2 0.0001
332 DYSURIA 4 0.0001
333 PRODUCT DISTRIBUTION ISSUE 1 0.0001
334 NEPHROPATHY 1 0.0001
335 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
336 SQUAMOUS CELL CARCINOMA 1 0.0001
337 SPINAL DISORDER 1 0.0001
338 HYPERCHOLESTEROLAEMIA 1 0.0001
339 BODY TEMPERATURE DECREASED 1 0.0001
340 SPINAL FRACTURE 2 0.0001
341 TOXIC SKIN ERUPTION 1 0.0001
342 HYPOTHERMIA 1 0.0001
343 SUBARACHNOID HAEMORRHAGE 1 0.0001
344 TENDERNESS 1 0.0001
345 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
346 FULL BLOOD COUNT ABNORMAL 1 0.0001
347 SKIN CANCER 2 0.0001
348 LACTIC ACIDOSIS 3 0.0001
349 IMPAIRED HEALING 3 0.0001
350 WOUND INFECTION 1 0.0001
351 ASPIRATION 1 0.0001
352 BLOOD GLUCOSE FLUCTUATION 1 0.0001
353 ANGIOEDEMA 4 0.0001
354 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
355 EYE INFECTION 1 0.0001
356 STATUS EPILEPTICUS 1 0.0001
357 HAEMATURIA 3 0.0001
358 CHOLECYSTECTOMY 1 0.0001
359 MUSCLE TWITCHING 2 0.0001
360 METASTASES TO LUNG 1 0.0001
361 BACTERAEMIA 1 0.0001
362 MYOCLONUS 1 0.0001
363 MACULAR DEGENERATION 1 0.0001
364 MUSCLE RIGIDITY 1 0.0001
365 THYROID CANCER 1 0.0001
366 NO THERAPEUTIC RESPONSE 1 0.0001
367 DISCOMFORT 5 0.0001
368 ENCEPHALOPATHY 2 0.0001
369 APPLICATION SITE IRRITATION 1 0.0001
370 DERMATITIS ALLERGIC 1 0.0001
371 MYDRIASIS 1 0.0001
372 SWELLING FACE 5 0.0001
373 NODULE 1 0.0001
374 BEDRIDDEN 1 0.0001
375 RESPIRATORY ARREST 2 0.0001
376 DEVICE OCCLUSION 1 0.0001
377 SEIZURE 8 0.0001
378 ANOSMIA 1 0.0001
379 GASTROENTERITIS 1 0.0001
380 DRUG WITHDRAWAL SYNDROME NEONATAL 1 0.0001
381 COLON CANCER 1 0.0001
382 APHASIA 2 0.0001
383 OSTEOPENIA 1 0.0001
384 CHRONIC KIDNEY DISEASE 5 0.0001
385 TINNITUS 3 0.0001
386 ANKLE FRACTURE 1 0.0001
387 SWELLING 6 0.0001
388 MENINGIOMA 1 0.0001
389 SWOLLEN TONGUE 2 0.0001
390 HEAD INJURY 2 0.0001
391 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
392 OBESITY 1 0.0001
393 SCIATICA 1 0.0001
394 HIP FRACTURE 2 0.0001
395 DRY EYE 3 0.0001
396 BLOOD UREA INCREASED 1 0.0001
397 CELLULITIS 3 0.0001
398 FACE OEDEMA 1 0.0001
399 METASTASES TO LIVER 1 0.0001
400 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
401 BRADYCARDIA 3 0.0001
402 LYMPHADENOPATHY 2 0.0001
403 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
404 OFF LABEL USE 48 0.0001
405 HYPERSENSITIVITY 10 0.0001
406 OXYGEN SATURATION DECREASED 3 0.0001
407 DYSARTHRIA 2 0.0001
408 BLOOD SODIUM DECREASED 1 0.0001
409 RENAL FAILURE 7 0.0001
410 MUSCULOSKELETAL DISORDER 1 0.0001
411 SLEEP APNOEA SYNDROME 1 0.0001
412 GLAUCOMA 1 0.0001
413 EAR PAIN 1 0.0001
414 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
415 CYTOKINE RELEASE SYNDROME 1 0.0000
416 BONE MARROW FAILURE 1 0.0000
417 PRODUCT PREPARATION ERROR 1 0.0000
418 CARDIAC ARREST 4 0.0000
419 TOXICITY TO VARIOUS AGENTS 8 0.0000
420 HALLUCINATION, VISUAL 1 0.0000
421 RHINORRHOEA 3 0.0000
422 PRODUCT DISPENSING ERROR 1 0.0000
423 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
424 SNEEZING 1 0.0000
425 THERAPY NON-RESPONDER 2 0.0000
426 CHROMATURIA 1 0.0000
427 HEART RATE IRREGULAR 1 0.0000
428 MUSCLE SPASMS 8 0.0000
429 SHOCK 1 0.0000
430 DYSPHAGIA 4 0.0000
431 PULMONARY EMBOLISM 4 0.0000
432 EMOTIONAL DISTRESS 5 0.0000
433 MENTAL IMPAIRMENT 1 0.0000
434 PRESYNCOPE 1 0.0000
435 NEURALGIA 1 0.0000
436 CEREBRAL INFARCTION 1 0.0000
437 LUNG DISORDER 2 0.0000
438 ABASIA 1 0.0000
439 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
440 AGEUSIA 1 0.0000
441 HYPOAESTHESIA 6 0.0000
442 HYPOTENSION 8 0.0000
443 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
444 ABDOMINAL PAIN LOWER 1 0.0000
445 FLUSHING 4 0.0000
446 FLUID RETENTION 2 0.0000
447 ACUTE KIDNEY INJURY 6 0.0000
448 HYPOPHAGIA 1 0.0000
449 LOSS OF CONSCIOUSNESS 5 0.0000
450 ERECTILE DYSFUNCTION 1 0.0000
451 ERYTHEMA 8 0.0000
452 HYPERHIDROSIS 5 0.0000
453 DEAFNESS 1 0.0000
454 ANHEDONIA 1 0.0000
455 CARDIAC FAILURE 3 0.0000
456 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
457 FEAR 1 0.0000
458 DRUG EFFECT DECREASED 2 0.0000
459 OVERDOSE 8 0.0000
460 BLOOD BILIRUBIN INCREASED 1 0.0000
461 INFLUENZA LIKE ILLNESS 3 0.0000
462 RESPIRATORY DISTRESS 1 0.0000
463 ANAPHYLACTIC REACTION 2 0.0000
464 HAEMOPTYSIS 1 0.0000
465 URTICARIA 6 0.0000
466 HYPONATRAEMIA 2 0.0000
467 ANGINA PECTORIS 1 0.0000
468 INTENTIONAL PRODUCT MISUSE 3 0.0000
469 TACHYCARDIA 3 0.0000
470 WHEEZING 2 0.0000
471 BLOOD POTASSIUM DECREASED 1 0.0000
472 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
473 PRODUCT USE ISSUE 6 0.0000
474 NEUROPATHY PERIPHERAL 3 0.0000
475 HYPOTHYROIDISM 1 0.0000
476 METABOLIC ACIDOSIS 1 0.0000
477 MOVEMENT DISORDER 1 0.0000
478 HEART RATE INCREASED 3 0.0000
479 EXPIRED PRODUCT ADMINISTERED 1 0.0000
480 SYNCOPE 3 0.0000
481 GAIT INABILITY 1 0.0000
482 TYPE 2 DIABETES MELLITUS 1 0.0000
483 CHEST DISCOMFORT 3 0.0000
484 DELIRIUM 1 0.0000
485 HEADACHE 18 0.0000
486 HAEMORRHAGE 3 0.0000
487 PRURITUS 11 0.0000
488 HEART RATE DECREASED 1 0.0000
489 HYPERTENSION 6 0.0000
490 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
491 CEREBRAL HAEMORRHAGE 1 0.0000
492 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
493 DRUG EFFECT INCOMPLETE 1 0.0000
494 PANIC ATTACK 1 0.0000
495 RESTLESSNESS 1 0.0000
496 AGITATION 2 0.0000
497 EPISTAXIS 2 0.0000
498 DYSPNOEA EXERTIONAL 1 0.0000
499 MUSCULAR WEAKNESS 3 0.0000
500 BLOOD PRESSURE INCREASED 4 0.0000
501 PALPITATIONS 3 0.0000
502 CHILLS 3 0.0000
503 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
504 DRUG INTERACTION 4 0.0000
505 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
506 OEDEMA PERIPHERAL 3 0.0000
507 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
508 ANXIETY 7 0.0000
509 OSTEOPOROSIS 1 0.0000
510 PRODUCT USE IN UNAPPROVED INDICATION 6 0.0000
511 TREMOR 4 0.0000
512 CARDIO-RESPIRATORY ARREST 1 0.0000
513 HYPOACUSIS 1 0.0000
514 BALANCE DISORDER 2 0.0000
515 SEPTIC SHOCK 1 0.0000
516 INSOMNIA 6 0.0000
517 DEHYDRATION 3 0.0000
518 PRODUCT QUALITY ISSUE 3 0.0000
519 NO ADVERSE EVENT 4 0.0000
520 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
521 MEMORY IMPAIRMENT 3 0.0000
522 SKIN IRRITATION 1 0.0000
523 SKIN DISCOLOURATION 1 0.0000
524 HYPOKALAEMIA 1 0.0000
525 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
526 BLOOD CHOLESTEROL INCREASED 1 0.0000
527 BLOOD GLUCOSE INCREASED 4 0.0000
528 ARRHYTHMIA 1 0.0000
529 DISEASE RECURRENCE 1 0.0000
530 MIGRAINE 2 0.0000
531 RASH ERYTHEMATOUS 1 0.0000
532 CONTUSION 2 0.0000
533 INFECTION 3 0.0000
534 DRUG INTOLERANCE 2 0.0000
535 DYSPEPSIA 2 0.0000
536 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
537 NERVOUSNESS 1 0.0000
538 MUSCULOSKELETAL PAIN 1 0.0000
539 SPEECH DISORDER 1 0.0000
540 PANCREATITIS 1 0.0000
541 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
542 PLATELET COUNT DECREASED 2 0.0000
543 DISTURBANCE IN ATTENTION 1 0.0000
544 MEDICATION ERROR 1 0.0000
545 PAIN 11 0.0000
546 THROMBOCYTOPENIA 2 0.0000
547 BLISTER 1 0.0000
548 DEATH 15 0.0000
549 PYREXIA 6 0.0000
550 FATIGUE 13 0.0000
551 FEELING ABNORMAL 4 0.0000
552 PLEURAL EFFUSION 1 0.0000
553 VERTIGO 1 0.0000
554 FEELING HOT 1 0.0000
555 CHEST PAIN 3 0.0000
556 DIZZINESS 8 0.0000
557 GAIT DISTURBANCE 3 0.0000
558 FALL 5 0.0000
559 SOMNOLENCE 3 0.0000
560 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
561 BURNING SENSATION 1 0.0000
562 INJURY 1 0.0000
563 DYSPNOEA 8 0.0000
564 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
565 SKIN BURNING SENSATION 1 0.0000
566 RESPIRATORY FAILURE 1 0.0000
567 DYSGEUSIA 1 0.0000
568 ASTHENIA 5 0.0000
569 DIABETES MELLITUS 1 0.0000
570 NAUSEA 10 0.0000
571 INJECTION SITE HAEMORRHAGE 1 0.0000
572 CONFUSIONAL STATE 2 0.0000
573 DRY MOUTH 1 0.0000
574 TREATMENT FAILURE 1 0.0000
575 COMPLETED SUICIDE 1 0.0000
576 RENAL IMPAIRMENT 1 0.0000
577 CEREBROVASCULAR ACCIDENT 2 0.0000
578 MYALGIA 2 0.0000
579 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
580 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
581 GASTROINTESTINAL DISORDER 1 0.0000
582 ADVERSE DRUG REACTION 1 0.0000
583 NASOPHARYNGITIS 2 0.0000
584 CARDIAC DISORDER 1 0.0000
585 ALOPECIA 2 0.0000
586 PAIN IN EXTREMITY 3 0.0000
587 SINUSITIS 1 0.0000
588 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
589 DIARRHOEA 6 0.0000
590 PNEUMONIA 3 0.0000
591 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
592 RASH 4 0.0000
593 SEPSIS 1 0.0000
594 ASTHMA 1 0.0000
595 VOMITING 4 0.0000
596 JOINT SWELLING 1 0.0000
597 PSORIASIS 1 0.0000
598 NEUTROPENIA 1 0.0000
599 WEIGHT DECREASED 2 0.0000
600 MALAISE 3 0.0000
601 DRUG INEFFECTIVE 9 0.0000
602 CONDITION AGGRAVATED 2 0.0000
603 ABDOMINAL DISCOMFORT 1 0.0000
604 URINARY TRACT INFECTION 1 0.0000
605 MYOCARDIAL INFARCTION 1 0.0000
606 COVID-19 1 0.0000
607 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
608 ARTHRALGIA 2 0.0000
609 CONSTIPATION 1 0.0000
610 WEIGHT INCREASED 1 0.0000
611 DEPRESSION 1 0.0000
612 INCORRECT DOSE ADMINISTERED 1 0.0000
613 DECREASED APPETITE 1 0.0000
614 BACK PAIN 1 0.0000
615 COUGH 1 0.0000
616 PRODUCT DOSE OMISSION ISSUE 1 0.0000
617 INJECTION SITE PAIN 1 0.0000